10 healthy client-owned large-breed Dogs were enrolled in this prospective clinical trial.
Before surgery, all dogs underwent physical examination and diagnostic evaluation to ensure normal health status.
Dogs were fed a prescription diet for 6 weeks before determination of gastrointestinal transit with a wireless motility capsule.
LAG was then performed, and dogs were fed the diet for 6 additional weeks. Measurement of transit times was repeated 6 weeks after surgery.
Ten dogs of various breeds at-risk for GDV were enrolled.
No complications were encountered associated with surgery or capsule administration.
There were no significant differences in GET 429 [306–1,370] versus 541 [326–1,298] (P = 0.80), SLBTT 1,243 [841–3,070] versus 1,540 [756–2,623] (P = 0.72), or TTT 1,971 [1,205–3,469] versus 1,792 [1,234–3,343] minutes (median, range) (P = 0.65) before and after LAG.
An effect of LAG on gastrointestinal transit time was not identified, and wireless motility capsule can be safely administered in dogs after LAG.
Source: Balsa, I.M., Culp, W.T.N., Drobatz, K.J., Johnson, E.G., Mayhew, P.D. and Marks, S.L. (2017), Effect of Laparoscopic-assisted Gastropexy on Gastrointestinal Transit Time in Dogs. Journal of Veterinary Internal Medicine, 31: 1680–1685. doi: 10.1111/jvim.14816
|
